Impact of the Pre-Procedural Pan-Immune Inflammation Value on Long-Term Mortality in Patients With Peripheral Artery Disease Following Endovascular Treatment: A Comparative Study
- 31 October 2025
- journal article
- Published by SAGE Publications in Angiology
Abstract
Chronic inflammation significantly impacts the progression and prognosis of peripheral artery disease (PAD). The pan-immune inflammation value (PIV), an integrated biomarker reflecting various immune-inflammatory components, may provide superior prognostic insights for PAD patients treated by endovascular intervention. This retrospective analysis included 282 patients who underwent endovascular treatment for PAD between 2018 and 2022. Pre-procedural blood samples were used to calculate PIV and other inflammatory indices. The primary endpoint was long-term mortality, evaluated by receiver operating characteristic analyses and Cox proportional hazards modeling. PIV showed the highest predictive accuracy for mortality (area under curve [AUC] = 0.72), surpassing the neutrophil-to-lymphocyte ratio (NLR; AUC = 0.65), systemic immune-inflammation index (SII; AUC = 0.67), platelet-to-lymphocyte ratio (PLR; AUC = 0.61), and systemic inflammation response index (SIRI; AUC = 0.58). In multivariate analysis adjusted for significant confounders, pre-procedural PIV emerged as an independent predictor of mortality (HR [Hazard ratio]: 1.89; 95% CI: 1.42-2.51; P <.001). These findings highlight the superior clinical utility of PIV as a prognostic biomarker, demonstrating its enhanced effectiveness in risk stratification compared with other inflammatory indices such as NLR, SII, PLR, and SIRI in patients with PAD following endovascular intervention. The integration of PIV into routine clinical assessment may improve prognostic accuracy and facilitate more informed and individualized decision-making.Keywords
This publication has 35 references indexed in Scilit:
- The role of inflammation biomarkers in carotid artery stenosis proceduresAnnals of Vascular Surgery, 2024
- A Simple Predictor for Long-Term Mortality After Percutaneous Iliac Artery Intervention: Systemic Immune Inflammatory IndexAnnals of Vascular Surgery, 2023
- Higher Systemic Immune-Inflammation Index is Associated With Higher Likelihood of Peripheral Arterial DiseaseAnnals of Vascular Surgery, 2022
- The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line TherapyTargeted Oncology, 2021
- Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Predict Severity and Prognosis of Lower Limb Arteriosclerosis ObliteransAnnals of Vascular Surgery, 2020
- Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: A meta-analysis of observational studiesAtherosclerosis, 2014
- Monocytes as a diagnostic marker of cardiovascular diseasesImmunobiology, 2012
- Finnvasc score and modified Prevent III score predict long-term outcome after infrainguinal surgical and endovascular revascularization for critical limb ischemiaJournal of Vascular Surgery, 2010
- Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgeryJournal of Vascular Surgery, 2007
- Comparison of Usefulness of Inflammatory Markers in Patients With Versus Without Peripheral Arterial Disease in Predicting Adverse Cardiovascular Outcomes (Myocardial Infarction, Stroke, and Death)The American Journal of Cardiology, 2005